Share This Page

Duquesne University study aims to curb bone loss

It is widely known that women start losing bone density as they get older.

Some women develop osteoporosis, a disease that thins and weakens bones to the point that they break easily.

A Duquesne University professor is studying a way to prevent bone deterioration using the over-the-counter hormone melatonin.

Melatonin supplements are widely used for sleep disorders and jet lag. But in addition to regulating the wake cycle, melatonin can help produce more cells that make bone, said Paula Witt-Enderby, a professor of pharmacology at Duquesne.

Her research targets women at the beginning of menopause, an ideal group because they have not yet experienced bone loss, Witt-Enderby said.

”We are approaching this from a quality-of-life issue,” she said. “We're trying to make the woman sleep better, help regulate her internal clocks so she feels better and at the same time the bones won't get destroyed.”

Witt-Enderby, who is doing the research in collaboration with Dr. Judith Balk of Magee-Womens Hospital, said melatonin could be a safe way to protect the bones. The National Osteoporosis Foundation estimates that about 10 million Americans have osteoporosis, and 80 percent of them are women.

Six women have completed the trial, and researchers want to recruit 14 more. They must be older than 45 and meet several criteria. If they qualify, they will undergo a bone density test and obtain information to improve their bone health. Women in the study will take either melatonin or a placebo. They will take it at night because its release is stimulated by darkness and suppressed by light.

Witt-Enderby wants to secure funding for a second phase of the study, possibly in about a year, to determine the effects of melatonin in post-menopausal women. For details about the Duquesne University study of melatonin and bone density in older women, call 412-396-5874.

TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.